Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol-CR in Medically-refractory Epilepsy
NCT00524134Phase 3Terminated
- Sponsor
- Columbia University
- Start
- Dec 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carvedilol in epilepsy, sponsored by Columbia University. Started Dec 2008; status: terminated.
02
Drugs
carvedilol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00524134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524134.